Gastrointestinal Over-the-counter (OTC) Drugs Market 2024-2028
The gastrointestinal over-the-counter (OTC) drugs market is forecasted to grow by USD 5266.2 mn during 2023-2028, accelerating at a CAGR of 5.55% during the forecast period. The report on the gastrointestinal over-the-counter (OTC) drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in prevalence of gastrointestinal disorders, easy availability and affordability of gastrointestinal OTC drugs, and availability of multiple payment options.
Technavio's gastrointestinal over-the-counter (OTC) drugs market is segmented as below:
- By Product
- Antacid
- Laxatives
- Anti-diarrheal
- Anti-emetics
- Others
- By Distribution Channel
- Offline
- Online
- By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increase in adoption of online platforms for gastrointestinal OTC drugs as one of the prime reasons driving the gastrointestinal over-the-counter (OTC) drugs market growth during the next few years. Also, rise in number of drug approvals and shift by pharmaceutical companies from prescription to gastrointestinal OTC drugs will lead to sizable demand in the market.
The report on the gastrointestinal over-the-counter (OTC) drugs market covers the following areas:
- Gastrointestinal over-the-counter (OTC) drugs market sizing
- Gastrointestinal over-the-counter (OTC) drugs market forecast
- Gastrointestinal over-the-counter (OTC) drugs market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gastrointestinal over-the-counter (OTC) drugs market vendors that include Abbott Laboratories, AbbVie Inc., Bausch Health Companies Inc., Bayer AG, Boehringer Ingelheim International GmbH, Cipla Inc., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., GlaxoSmithKline Plc, Haleon Plc, Johnson and Johnson Services Inc., Merck KGaA, Novartis AG, Pfizer Inc., Phathom Pharmaceuticals Inc., Prestige Consumer Healthcare Inc., Sanofi SA, SonoScape Medical Corp., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Vee Excel Drugs And Pharmaceuticals Pvt. Ltd., and Zoic Pharmaceuticals Pvt. Ltd.. Also, the gastrointestinal over-the-counter (OTC) drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.